Effect of Drug Therapy on Reinfarction Risk in Women
2 other identifiers
observational
N/A
0 countries
N/A
Brief Summary
To evaluate the safety of calcium-channel blockers in the secondary prevention of myocardial infarction in women.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Sep 1995
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 1995
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 1998
CompletedFirst Submitted
Initial submission to the registry
May 25, 2000
CompletedFirst Posted
Study publicly available on registry
May 26, 2000
CompletedFebruary 10, 2016
April 1, 2001
May 25, 2000
February 8, 2016
Conditions
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
Related Publications (2)
Heckbert SR, Weiss NS, Koepsell TD, Lemaitre RN, Smith NL, Siscovick DS, Lin D, Psaty BM. Duration of estrogen replacement therapy in relation to the risk of incident myocardial infarction in postmenopausal women. Arch Intern Med. 1997 Jun 23;157(12):1330-6.
PMID: 9201007BACKGROUNDKaplan RC, Heckbert SR, Weiss NS, Wahl PW, Smith NL, Newton KM, Psaty BM. Postmenopausal estrogens and risk of myocardial infarction in diabetic women. Diabetes Care. 1998 Jul;21(7):1117-21. doi: 10.2337/diacare.21.7.1117.
PMID: 9653605BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
May 25, 2000
First Posted
May 26, 2000
Study Start
September 1, 1995
Study Completion
August 1, 1998
Last Updated
February 10, 2016
Record last verified: 2001-04